Shanghai INT Medical Instruments Co., Ltd. (HKG:1501)
26.50
+0.40 (1.53%)
Apr 24, 2025, 4:08 PM HKT
HKG:1501 Revenue
In the year 2024, Shanghai INT Medical Instruments had annual revenue of 851.95M CNY with 13.17% growth. Shanghai INT Medical Instruments had revenue of 459.63M in the half year ending December 31, 2024, with 27.44% growth.
Revenue
851.95M CNY
Revenue Growth
+13.17%
P/S Ratio
5.07
Revenue / Employee
491.04K CNY
Employees
1,735
Market Cap
4.59B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 851.95M | 99.12M | 13.17% |
Dec 31, 2023 | 752.84M | 166.95M | 28.50% |
Dec 31, 2022 | 585.88M | 121.21M | 26.08% |
Dec 31, 2021 | 464.68M | 106.25M | 29.64% |
Dec 31, 2020 | 358.43M | 71.97M | 25.12% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
CSPC Pharmaceutical Group | 30.87B |